Advertisement

Physiopathology of Sudden Cardiac Death

  • S. Nodari
  • M. Metra
  • N. Pezzali
  • C. Giovannelli
  • G. Milesi
  • L. Dei Cas
Conference paper

Abstract

Sudden cardiac death (SCD) is unexpected natural death due to cardiac causes, with abrupt loss of consciousness within 1 h of the onset of acute symptoms, with or without pre-existing heart disease. It is very hard to assess the exact incidence of SCD because of variability in the definition of the concept of “sudden” [1,2]. We are not discussing death occurring 1 h after syncope in a healthy subject, but the definition is not completely clear in a cardiopathic patient with ventricular fibrillation as the end-stage event in a worsened clinical status.

Keywords

Heart Rate Variability Acute Myocardial Infarction Sudden Cardiac Death Ventricular Fibrillation Sympathetic Hyperactivity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Stoupel E, Jottrand M (2001) Sudden cardiac death. Rev Med Brux 22: 488–498PubMedGoogle Scholar
  2. 2.
    Myerburg RJ, Castellanos A (2001) Cardiac arrest and sudden cardiac death. In: Braunwald E, Zipes DP, Libby P (ed) Heart disease: a textbook of cardiovascular medicine, 6th edn. Elsevier Science, New YorkGoogle Scholar
  3. 3.
    Myerburg RJ (2001) Sudden cardiac death: exploring the limits of our knowledge. J Cardiovasc Electrophisiol 12:369–381CrossRefGoogle Scholar
  4. 4.
    Myerburg RJ, Interian A Jr, Mitrani RM, Kessler KM, Castellanos A (1997) Frequency of sudden cardiac death and profiles of risk. Am J Cardiol 80(5B):10F–19FPubMedCrossRefGoogle Scholar
  5. 5.
    Myerburg RJ, Kessler KM, Castellanos A (1993) Sudden cardiac death: epidemiology, transient risk and intervention assessment. Ann Intern Med 119:1187–1197PubMedCrossRefGoogle Scholar
  6. 6.
    Goldstein MR (2001) Sudden death due to cardiac arrhythmias. N Engl J Med 345:1473–1482CrossRefGoogle Scholar
  7. 7.
    Kannel WB, Schatzkin A (1985) Sudden death: lessons from subsets in population studies. J Am Coll Cardiol 5(6 Suppl):141B–149BPubMedCrossRefGoogle Scholar
  8. 8.
    Smith SC Jr, Blair SN, Bonow RO et al (2001) AHA/ACC Scientific Statement. AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: a statement for health care professionals from the American Heart Association and the American College of Cardiology. Circulation 104:1577–1579PubMedCrossRefGoogle Scholar
  9. 9.
    Solomon SD, Antman E (1993) Prehospital thrombolytic therapy for myocardial infarction. N Engl J Med 329:383–389CrossRefGoogle Scholar
  10. 10.
    Disertori M, Dallafior D, Marini M (2001) Arrhythmia risk stratification based on etiological and anatomo-structural factors. Ital Heart J 2(12 Suppl):1265–1269Google Scholar
  11. 11.
    Sweeney MO (2001) Sudden death in heart failure associated with reduced left ventricular function: substrates, mechanisms and evidence-based management. Part I. Pacing Clin Electrophysiol 24:871–888PubMedCrossRefGoogle Scholar
  12. 12.
    Bigger JT Jr, Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM (1984) The relationships among ventricular arrhyhtmias, left ventricular dysfunction and mortality in the 2 years after myocardial infarction. Circulation 69:250–258PubMedCrossRefGoogle Scholar
  13. 13.
    Kjekshus J (1990) Arrhythmia and mortality in congestive heart failure. Am J Cardiol 65:42-ICrossRefGoogle Scholar
  14. 14.
    Zipes DP, Wellens HJ (1998) Sudden cardiac death. Circulation 98:2334–2351PubMedCrossRefGoogle Scholar
  15. 15.
    Anonymous (1997) Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomized trials. Amiodarone Trials Meta-Analysis Investigators. Lancet 350:1417–1424CrossRefGoogle Scholar
  16. 16.
    Domanski MJ, Exner DV, Borkowf CB, Geller NL, Rosenberg Y, Pfeffer MA (1999) Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction. A meta-analysis of randomized clinical trials. J Am Coll Cardiol 33:598–604PubMedCrossRefGoogle Scholar
  17. 17.
    Kim D, Duff RA (1990) Regulation of K+ channels in cardiac myocytes by free fatty acids. Circ Res 67:1040–1046PubMedCrossRefGoogle Scholar
  18. 18.
    Pound EM, Kang JX, Leaf A (2001) Partitioning of polyunsatured fatty acids, which prevent cardiac arrhythmias, into phospholipid cell membranes. J Lipid Res 42:346–351PubMedGoogle Scholar
  19. 19.
    Leaf A (2001) Electrophysiologic basis for the antiarrhythmic and anticonvulsant effects of omega 3 polyunsaturated fatty acids. World Rev Nutr Diet 88:72–78PubMedCrossRefGoogle Scholar
  20. 20.
    De Caterina R, Madonna R (2002) Antiarrhythmic effects of omega-3 fatty acids. A review. Ital Heart J 3(3 Suppl):297–308Google Scholar
  21. 21.
    Lundmark K, Abelnoor M, Urdal P et al (1998) Use of fish oils appears to reduce infarct size as estimated from peak creatinekinase and loctate dehydrogenase activities. Cardiology 89:94–102CrossRefGoogle Scholar
  22. 22.
    Christensen JH, Dyerberg J, Schmidt EB (1999) n-3 fatty acids and the risk of sudden cardiac death assessed by 24-hour heart rate variability. Lipids 34[Suppl]:S197CrossRefGoogle Scholar
  23. 23.
    Christensen JH, Kroup E, Aaroe J, Toft E, Moller J, Rasmussen K, Dyerberg J, Schmidt EB (1997) Fish consumption, n-3 fatty acids in cell membranes, and heart rate variability in survivors of myocardial infarction with left ventricular dysfunction. Am J Cardiol 79:1670–1673PubMedCrossRefGoogle Scholar
  24. 24.
    Christensen HJ, Skou HA, Fog L, Hansen V, Vesterlund T, Dyerberg J, Toft E, Schmidt EB (2001) Marine n-3 fatty acids, wine intake, and heart rate variability in patients referred for coronary angiography. Circulation 103:651–657PubMedCrossRefGoogle Scholar
  25. 25.
    Christensen JH, Skou HA, Madsen T, Torring I, Schmidt EB (2001) Heart rate variability and n-3 polyunsaturated fatty acids in patients with diabetes mellitus. J Intern Med 249:545–552PubMedCrossRefGoogle Scholar
  26. 26.
    Barron HV, Viskin S (1998) Autonomic markers and prediction of cardiac death after myocardial infarction. Lancet 351:461–462PubMedCrossRefGoogle Scholar
  27. 27.
    Xiao YF, Wright SN, Wang JK, Morgan JP, Leaf A (2000) Coexpression with beta(1) subunit modifies the kinetics and fatty acid block of hHl (alpha) Na+ channels. Am J Physiol Heart Circ Physiol 279:H35–46PubMedGoogle Scholar
  28. 28.
    Bendahhou S, Cummins TR, Agnew WS (1997) Mechanism of modulation of the voltage-gated skeletal and cardiac muscle sodium channels by fatty acids. Am J Physiol 272(2Pt 1):C592–600PubMedGoogle Scholar
  29. 29.
    Pepe S, Bogdanov K, Hallaq H, Spurgeon H, Leaf A, Lakatta E (1994) Omega 3 polyunsaturated fatty acids modulate dihydropiridine effects on L-type Ca2+ channels, cytosolic Ca2+ and contraction in adult rat cardiac myocytes. Proc Natl Acad Sci USA 91(19): 8832–8836PubMedCrossRefGoogle Scholar
  30. 30.
    Kris-Etherton PM, Harris WS, Appel LJ (2002) Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106: 2747–2757PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2003

Authors and Affiliations

  • S. Nodari
    • 1
  • M. Metra
    • 1
  • N. Pezzali
    • 1
  • C. Giovannelli
    • 1
  • G. Milesi
    • 1
  • L. Dei Cas
    • 1
  1. 1.Cattedra di CardiologiaUniversità degli Studi di BresciaBresciaItaly

Personalised recommendations